|
| Status |
Public on Dec 14, 2020 |
| Title |
CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Sep 08, 2020 |
| Last update date |
Dec 14, 2020 |
| Contact name |
Musaddeque Ahmed |
| E-mail(s) |
musaddeque.ahmed@gmail.com
|
| Organization name |
University health Network
|
| Lab |
He Lab
|
| Street address |
101 College St
|
| City |
Toronto |
| State/province |
ON |
| ZIP/Postal code |
M5G1L7 |
| Country |
Canada |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (24)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE157527 |
CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [guide RNA] |
| GSE157617 |
CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy [RNA-Seq] |
|
| Relations |
| BioProject |
PRJNA662233 |
Less...
More...